Molecular testing in early breast cancer: Perspectives from a surgeon, radiation and medical oncologists
Supported by Lilly
Tuesday, October 19, 2021
20:00 (8:00PM) (AEDT)
Chairperson | Frances Boyle, Sydney, Australia |
20:00-20:05 | Welcome & Introduction Frances Boyle, Sydney, Australia |
20:05-20:17 | Selecting Patients with Luminal Tumours for Neoadjuvant chemotherapy Andrew Spillane, Sydney, Australia |
20:17-20:22 | Panel Discussion |
20:22-20:34 | Predicting the risk of recurrence in ER+ve early breast cancer: when and how do genomic assays help in our decision making? Belinda Yeo, Melbourne, Australia |
20:34-20:39 | Panel Discussion |
20:39-20:51 | The Clinical Utility of Genomic Assays on Radiation Therapy Decision Making in DCIS and Early Breast Cancer Gillian Lamoury, Sydney, Australia |
20:51-20:56 | Panel Discussion |
20:56-21:00 | Summary & Close Frances Boyle, Sydney, Australia |
MEET THE FACULTY
Fran Boyle, Australia | Gillian Lamoury, Australia | Andrew Spillane, Australia | Belinda Yeo, Australia |